New Mesothelioma Clinical Trial Will Test Personalized Immunotherapy
A Dutch company has recruited the first patients into a pivotal mesothelioma clinical trial of autologous dendritic cells. Dendritic cells…
-
-
Chemotherapy | Europe | International | New Studies | Research | Treatments
Patients with Impaired Kidneys Could Still Take Alimta for Mesothelioma, Study Finds
New research in the Netherlands suggests that patients who would not normally be prescribed Alimta for mesothelioma could still benefit… -
Asia | Chemotherapy | International | Multi-Modality Therapy | New Studies | Research | Surgery | Treatments | Updates
Chemotherapy During Mesothelioma Surgery: Is it Dangerous?
A new study finds that chemotherapy during mesothelioma surgery does not raise the risk for complications. That could be good… -
Asia | Chemotherapy | International | Surgery | Treatments
Conservative Surgery Leads to Better Mesothelioma Survival After Recurrence
Mesothelioma survival after recurrence may be better with lung-preserving P/D surgery than with more radical EPP. Japanese researchers recently analyzed… -
PARP Inhibitors Could Enhance Immunotherapy Response in Mesothelioma
A new study suggests that drugs known as PARP inhibitors may enhance immunotherapy response in mesothelioma patients. According to a… -
Europe | International | New Studies | Research | Symptoms | Treatments
Cancer Centers May Not Manage Mesothelioma Symptoms Adequately, Study Finds
UK researchers say the number of patients receiving palliative care to manage mesothelioma symptoms may be lagging behind the need.… -
Europe | International | New Studies | Research | Symptoms | Treatments
Predicting Thyroid Disease After Immunotherapy for Mesothelioma
Researchers in Italy say it is possible to predict which mesothelioma patients are likely to develop thyroid disease after immunotherapy.… -
Biopsy | Diagnosis | Surgery | Treatments
Staging of Mesothelioma Could Change with Discovery of New Lymph Nodes
A recent discovery at the University of Maryland could dramatically change how doctors handle the staging of malignant pleural mesothelioma.… -
Mesothelioma Research Demonstrates Power of Intrapleural Immunotherapy
New metadata suggests that intrapleural immunotherapy is a powerful, targeted way to treat malignant pleural mesothelioma. Pleural mesothelioma is… -
Adjuvant Radiotherapy for Mesothelioma Extends Survival
The largest study ever conducted on adjuvant radiotherapy for mesothelioma shows that it can help patients live longer. Pleural mesothelioma…
